China NMPA Drug Inspection - Shanghai Qingping Pharmaceutical Co., Ltd. - Bai Ziren
China NMPA drug inspection for Shanghai Qingping Pharmaceutical Co., Ltd. published June 01, 2017. Drug: Bai Ziren. The Shanghai Municipal Food and Drug Administration (SMFDA) released its 2017 Issue 2 Drug Supervision and Sampling Insp
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanghai Qingping Pharmaceutical Co., Ltd. published June 01, 2017. Drug: Bai Ziren. The Shanghai Municipal Food and Drug Administration (SMFDA) released its 2017 Issue 2 Drug Supervision and Sampling Insp
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox